Benjamin Chong, M.D.
Assistant Professor
Department: Dermatology
Assistant Professor
Department: Dermatology
General Dermatology Clinic
5939 Harry Hines Blvd
Suite 100
Dallas, Texas 75390-9191
214-645-2400
Dr. Benjamin F. Chong joined the Department of Dermatology at the University of Texas Southwestern Medical Center as an Assistant Instructor in 2008. He received a Magna Cum Laude in Chemistry at Harvard University in 1999, and his MD degree at the Johns Hopkins School of Medicine in 2004. He completed his internship in Internal Medicine at St. Joseph Mercy Hospital in Ann Arbor, Michigan, in 2005, and his dermatology residency at Henry Ford Hospital in Detroit, Michigan, in 2008. He served as the chief resident from 2007-2008. His clinical interests include cutaneous lupus erythematosus, dermatomyositis, and sarcoidosis. He is the principal investigator of the University of Texas Southwestern Cutaneous Lupus Patient Registry and has his own laboratory studying the pathogenesis of cutaneous lupus erythematosus.
| Graduate School | UT Southwestern Medical Center at Dallas () |
| Medical School | Johns Hopkins University (2004) |
| Residency | Saint Joseph Mercy Hospital-Ann Arbor, MI (2005) |
| Residency | Henry Ford Hospital (2008) |
| Other Post Graduate Training | UT Southwestern Medical Center (2009), Dermatology |
Featured Publications
Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus.
Vasquez R, Tseng LC, Victor S, Zhang S, Chong BF Arch Dermatol 2012 May 148 5 651-5
Chong BF, Song J, Olsen NJ Br. J. Dermatol. 2012 Jan 166 1 29-35
25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus erythematosus
Word AP, Perese F, Tseng LC, Adams-Huet B, Olsen NJ, Chong BF Br J Dermatol 2012 166 2 372-379
Risk factors for ANA positivity in healthy persons.
Li QZ, Karp DR, Quan J, Branch VK, Zhou J, Lian Y, Chong BF, Wakeland EK, Olsen NJ Arthritis research & therapy 2011 Mar 13 2 R38
Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus
Wang A*, Guilpain P*, Chong BF*, Chouzenoux S, Guillevin L, Du Y, Zhou XJ, Lin F, Fairhurst A, Boudreaux C, Roux C, Wakeland EK, Davis L, Batteux F, Mohan C (* - co-first-authors) Arthritis Rheum 2010 62 3436-3446
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus
Chong, BF, Mohan C Expert Opin Ther Targets October 2009 13(10) 1147-53
Vasquez R, Wang D, Tran QP, Adams-Huet B, Chren MM, Costner MI, Cohen JB, Werth VP, Chong BF Br. J. Dermatol. 2013 Jan 168 1 145-53
IgG and IgM autoantibody differences in discoid and systemic lupus patients.
Chong BF, Tseng LC, Lee T, Vasquez R, Li QZ, Zhang S, Karp DR, Olsen NJ, Mohan C J. Invest. Dermatol. 2012 Dec 132 12 2770-9
Chong BF, Dantzer P, Germeroth T, Hafner M, Wilson AJ, Xiao G, Wong HK J. Dermatol. Sci. 2010 Oct 60 1 8-20
Treatment of psoriasis with etanercept in patient with history of primary B-cell lymphoma
Chong, BF, Wong, HK Clin Exp Dermatol July 2009 34(5) e11-3
Featured Books
The cutaneous immune system: a skin-bsed perspective on immunology.. In Cutaneous Manifestations of Rheumatic Diseases, 2nd Ed
Chong BF, Kupper TS (2004). Philadelphia, PA, Lippincott, Williams and Wilkins
Skin disease in cutaneous lupus erythematosus.. In Dubois' Lupus Erythematosus and Related Syndromes, 8th Ed
Chong BF, Werth VP. (2013). Philadelphia, PA, Elsevier Saunders